Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- HC Wainwright & Co. analyst Ed Arce initiated coverage on MetaVia (NASDAQ:MTVA) with a Buy rating and announced a price target of $12. MetaVia shares closed at $1.76 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Raghuram Selvaraju initiated coverage on Emergent BioSolutions Inc. (NYSE:EBS) with a Buy rating and announced a price target of $15. Emergent BioSolutions shares closed at $8.27 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Swayampakula Ramakanth initiated coverage on Nuvalent, Inc. (NASDAQ:NUVL) with a Buy rating and announced a price target of $110. Nuvalent shares closed at $80.30 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Douglas Tsao initiated coverage on Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) with a Buy rating and announced a price target of $19. Arcutis Biotherapeutics shares closed at $14.30 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Edward White initiated coverage on Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) with a Buy rating and announced a price target of $20. Artiva Biotherapeutics shares closed at $10.64 on Friday. See how other analysts view this stock.
Considering buying NUVL stock? Here's what analysts think:
Read This Next:
- How To Earn $500 A Month From RPM International Stock Ahead Of Q2 Earnings
